Registry for blind individuals with sleep problems
Development of a Patient Registry of Blind Subjects With Sleep-related Problems
Vanda Pharmaceuticals · NCT01195558
This study is creating a registry for totally blind people with sleep problems to gather information that can help researchers understand and address their sleep issues better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Sex | All |
| Sponsor | Vanda Pharmaceuticals (industry) |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT01195558 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a patient registry for individuals who are totally blind and may experience Non-24-hour sleep-wake disorder. Participants will engage in a phone survey to provide information about their vision impairment and sleep issues. The registry will help researchers understand sleep-related problems in blind individuals and may facilitate future clinical studies and treatment investigations. The data collected will also raise awareness about Non-24 and its impact on this population.
Who should consider this trial
Good fit: Ideal candidates for this study are blind individuals aged 18 and older who experience sleep problems or daytime sleepiness.
Not a fit: Patients who are not blind or do not experience sleep-related issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and management of sleep disorders in blind individuals.
How similar studies have performed: While this approach is focused on a specific population, similar studies have shown success in understanding sleep disorders, indicating potential for valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects or legal guardians must be at least 18 years of age to participate in the telephone survey. Parents or legal guardians may represent children from 0 through 17 years who meet the following criteria. 2. Subjects must be blind. 3. Subjects must have some self-described problem with sleep or daytime sleepiness.
Where this trial is running
Washington D.C., District of Columbia
- Vanda Pharmaceuticals — Washington D.C., District of Columbia, United States (RECRUITING)
Study contacts
- Study coordinator: Vanda Pharmaceuticals
- Phone: (202) 734-3400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Sleep-wake Disorder in Blind Individuals, Non-24, N24HSWD, Blindness, Sleep, Wake, Circadian Rhythm, Nap